Patent Assignment
Reel/Frame 058171/0087
Assignment of Assignor's Interest
Recorded: 2021-11-17
Pages: 24
Assignors
SAVIENT PHARMACEUTICALS, INC.
Executed: 2014-01-09
SAVIENT PHARMA HOLDINGS, INC.
Executed: 2014-01-09
Assignee
CREALTA PHARMACEUTICALS LLC
150 S. SAUNDERS RD SUITE 130, LAKE FOREST, ILLINOIS, 60045
Covered Properties
(2)
Variant Forms of Urate Oxidase and Use Thereof
Variant Forms of Urate Oxidase and Use Thereof
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest
Nov 17, 2021
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 058137/0157 →
Change of Name
Nov 17, 2021
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 058171/0141 →
Change of Name
Nov 17, 2021
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 058176/0421 →
Assignment of Assignor's Interest
Apr 15, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 059721/0849 →
Assignment of Assignor's Interest
Oct 31, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC
Reel/Frame 061805/0076 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Dec 1, 2022
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 062073/0930 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →